We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Dysfunction in Fibromyalgia Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01655537
First Posted: August 2, 2012
Last Update Posted: September 17, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Rena Cooper, Hadassah Medical Organization
  Purpose

Fibromyalgia is a common rheumatologic disorder. Many patients complain of cognitive dysfunction as part of their symptoms.

The investigators aim to assess this cognitive dysfunction through extensive neuro-cognitive testing.


Condition
Fibromyalgia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cognitive Dysfunction in Fibromyalgia Patients: Specific Neuro-psychological Dysfunctions, Psychiatric Comorbidity and Integrative Assessments

Resource links provided by NLM:


Further study details as provided by Rena Cooper, Hadassah Medical Organization:

Enrollment: 25
Study Start Date: July 2012
Study Completion Date: September 2013
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
fibromyalgia patients
Criteria

Inclusion Criteria:

  1. Primary fibromyalgia as defined by the American College of Rheumatology
  2. Age 18-70 years
  3. Male or female
  4. Competent and willing to give written informed consent

Exclusion Criteria:

  1. History of head trauma
  2. Any significant neurological disorder that may confound neuro-cognitive testing
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01655537


Locations
Israel
Hadassah Medical Organization-PSYCHIATRIC CLINIC
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: RENA COOPER-KAZAZ, Dr. Hadassah Medical Organization
  More Information

Responsible Party: Rena Cooper, Psychiatric Outpatient Clinic-Head, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01655537     History of Changes
Other Study ID Numbers: COG-FM-HMO-CTIL
First Submitted: July 31, 2012
First Posted: August 2, 2012
Last Update Posted: September 17, 2013
Last Verified: September 2013

Keywords provided by Rena Cooper, Hadassah Medical Organization:
fibromyalgia
cognitive dysfunction

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Cognitive Dysfunction
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases
Cognition Disorders
Neurocognitive Disorders
Mental Disorders